VYGR logo

Voyager Therapeutics (VYGR)

Profile

Full Name

Voyager Therapeutics, Inc.

Ticker Symbol

VYGR

Exchange

NASDAQ

Sector

Healthcare

Industry

Biotechnology

Country

United States

IPO

November 11, 2015

Indexes

Not included

Website

http://www.voyagertherapeutics.com

Employees

172

Key Details

Price

$3.21(+0.63%)

Market cap

$177.21M(Small cap)

Last Dividend

-

TTM Dividend yield

-

Annual revenue

$80.00M(-68.00% YoY)

Annual EPS

-$1.13(-138.05% YoY)

PE ratio

-

Next earnings date

May 13, 2025

Next ex-dividend date

N/A

Next split date

N/A

Price

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Current Price

$3.21
VYGR price is $3.21

30-Day Relative Volume

0.75
VYGR 30-day relative volume is 0.75

Price Performance

Price Most recent change

+0.63%
VYGR price was up +0.63% on Apr 15, 2025

Price YTD change

-43.39%
VYGR price is down -43.39% since January 1st

Price 1-year change

-59.77%
VYGR price is down -59.77% year-on-year

Price 3-year change

-64.01%
VYGR price is down -64.01% over the past 3 years

Price Range

Price All-time high

$31.91
VYGR price is currently -89.94% below its historical high of $31.91

Price 3-year low

$2.75
VYGR price is currently +16.73% above its 3-year low

Capitalization

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Market cap

Market cap

$177.21M
VYGR market capitalization is $177.21 million

Market cap 3-year change

-48.27%
VYGR market capitalization is down -48.27% over the past 3 years

Market cap All-time high

$1.04B
VYGR market capitalization is currently -82.92% below its historical high of $1.04 billion

Market cap sector rank

55.67%
VYGR market capitalization is higher than 55.67% of companies in Healthcare sector

Shares Outstanding

Shares Outstanding 1-Year Change

+1.51%
VYGR shares outstanding is up +1.51% year-on-year

Shares Outstanding 3-Year Change

+43.76%
VYGR shares outstanding is up +43.76% over the past 3 years

Technical Indicators

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Beta

1.20
VYGR beta is 1.20

200-day SMA

$6.00
VYGR price is currently -46.53% below its 200-day simple moving average

50-day SMA

$3.98
VYGR price is currently -19.40% below its 50-day simple moving average

RSI

39.13
VYGR 14-day relative strength index is 39.13

Volume

0.75
VYGR 30-day relative volume is 0.75

ATR

$0.25
VYGR average true range is $0.25

10-day Historical Volatility

85.51%
VYGR 10-day historical volatility is 85.51%

Dividend

Income Statement

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Revenue

Revenue

$80.00M
VYGR annual revenue is $80.00 million

Revenue Analysts estimate

$66.14M
VYGR annual revenue is currently +20.95% higher than the consensus analysts' forecast

Revenue 1-year change

-68%
VYGR annual revenue is down -68% year-on-year

Revenue Sector rank

53.63%
VYGR annual revenue is higher than 53.63% of companies in Healthcare sector

EPS

EPS

-$1.13
VYGR annual earnings per share is -$1.13

EPS Analysts estimate

-$1.62
VYGR annual earnings per share is currently -30.31% lower than the consensus analysts' forecast

EPS 1-year change

-138.05%
VYGR annual earnings per share is down -138.05% year-on-year

EPS Sector rank

53.85%
VYGR annual earnings per share is higher than 53.85% of companies in Healthcare sector

Profit

Gross profit

-
VYGR annual gross profit value is unknown

Gross margin

-
VYGR annual gross profit margin value is unknown

Operating profit

-$83.29M
VYGR annual operating income is -$83.29 million

Operating margin

-104.11%
VYGR annual operating profit margin is -104.11%

Net income

-$65.00M
VYGR annual net profit is -$65.00 million

Net margin

-81.25%
VYGR annual net profit margin is -81.25%

Expenses

Total expenses

$163.29M
VYGR annual total expenses is $163.29 million

Operating expenses

$163.29M
VYGR annual total operating expenses is $163.29 million

Cost of goods sold

-
VYGR annual cost of goods sold value is unknown

Selling, general & administrative expenses

$35.92M
VYGR annual SGA is $35.92 million

Depreciation and amortization

$4.73M
VYGR annual depreciation & amortization is $4.73 million

Interest expense

-
VYGR annual interest expense value is unknown

Income tax

$665.00K
VYGR annual income tax is $665.00 thousand

EBIT & EBITDA

EBIT

-$83.29M
VYGR annual earnings before interest & taxes is -$83.29 million

EBITDA

-$78.56M
VYGR annual EBITDA is -$78.56 million

Balance Sheet

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Assets

Total assets

$393.05M
VYGR annual total assets is $393.05 million

Non current assets

$116.24M
VYGR annual long term assets is $116.24 million

Current assets

$276.81M
VYGR annual total current assets is $276.81 million

Cash and cash equivalents

$71.37M
VYGR annual cash & cash equivalents is $71.37 million

Accounts receivable

$1.50M
VYGR annual accounts receivable is $1.50 million

Inventory

-
VYGR annual inventory value is unknown

Liabilities

Total liabilities

$93.29M
VYGR annual total liabilities is $93.29 million

Long term liabilities

$43.50M
VYGR annual total long term liabilities is $43.50 million

Current liabilities

$49.79M
VYGR annual total current liabilities is $49.79 million

Accounts payable

$4.00M
VYGR annual accounts payable is $4.00 million

Debt

Total debt

$43.73M
VYGR annual total debt is $43.73 million

Total debt 1-year change

+115.46%
VYGR annual total debt is up +115.46% year-on-year

Long term debt

$36.50M
VYGR annual long term debt is $36.50 million

Short term debt

$7.23M
VYGR annual short term debt is $7.23 million

Equity & Capital

Shareholders equity

$299.76M
VYGR annual stockholders equity is $299.76 million

Book value

$299.76M
VYGR annual book value is $299.76 million

Retained earnings

-$326.18M
VYGR annual retained earnings is -$326.18 million

Working capital

$227.02M
VYGR annual working capital is $227.02 million

Cash Flow Statement

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Cashflow Activities

Cash from operations

-$15.31M
VYGR annual cash flow from operations is -$15.31 million

Cash from operations 1-year change

-119.65%
VYGR annual cash flow from operations is down -119.65% year-on-year

Cash from investing

-$94.86M
VYGR annual cash flow from investing activities is -$94.86 million

Cash from investing 1-year change

+33.03%
VYGR annual cash flow from investing activities is up +33.03% year-on-year

Cash from financing

$114.02M
VYGR annual cash flow from financing activities is $114.02 million

Cash from financing 1-year change

+238.88%
VYGR annual cash flow from financing activities is up +238.88% year-on-year

CAPEX

CAPEX

$3.52M
VYGR annual capital expenditures is $3.52 million

CAPEX 1-year change

+8.14%
VYGR annual capital expenditures is up +8.14% year-on-year

Free Cash Flow

Free cash flow

-$18.83M
VYGR annual free cash flow is -$18.83 million

Free cash flow 1-year change

-125.22%
VYGR annual free cash flow is down -125.22% year-on-year

Profitability Ratios

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Margins

Gross margin

-
VYGR annual gross profit margin value is unknown

Operating margin

-104.11%
VYGR annual operating profit margin is -104.11%

Net margin

-81.25%
VYGR annual net profit margin is -81.25%

ROA & ROE

ROA

-17.47%
VYGR annual return on assets is -17.47%

ROE

-24.25%
VYGR annual return on equity is -24.25%

Valuation

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

PE Ratio

PE ratio

-
VYGR price to earnings ratio value is unknown

PE ratio Sector rank

-
VYGR price to earnings ratio is unknown

PB Ratio

PB ratio

0.59
VYGR price to book ratio is 0.59

PB ratio Sector rank

32.43%
VYGR price to book ratio is higher than 32.43% of companies in Healthcare sector

PS Ratio

PS ratio

2.22
VYGR price to sales ratio is 2.22

PS ratio Sector rank

44.87%
VYGR price to sales ratio is higher than 44.87% of companies in Healthcare sector

Enterprise value

Enterprise value

$149.57M
VYGR enterprise value is $149.57 million

Enterprise value Sector rank

54.43%
VYGR enterprise value is higher than 54.43% of companies in Healthcare sector

EV/EBITDA

EV/EBITDA

-1.90
VYGR EV/EBITDA is -1.90

EV/EBITDA Sector rank

32.99%
VYGR EV/EBITDA is higher than 32.99% of companies in Healthcare sector

Financial Health

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Liquidity

Current ratio

5.56
VYGR annual current ratio is 5.56

Quick ratio

-
VYGR annual quick ratio value is unknown

Leverage

Debt to equity

0.00
VYGR annual debt to equity ratio is 0.00

Interest coverage ratio

-
VYGR annual interest coverage ratio value is unknown

Risk & Stability

Piotroski F-Score

-
VYGR piotroski f-score value is unknown

Altman Z-Score

0.18
VYGR altman z-score is 0.18

Analyst ratings

Recent major analysts updates

Apr 8, 25 HC Wainwright & Co.
Buy
Mar 13, 25 HC Wainwright & Co.
Buy
Mar 13, 25 Canaccord Genuity
Buy
Mar 12, 25 Wells Fargo
Overweight
Mar 12, 25 Wedbush
Outperform
Mar 12, 25 Cantor Fitzgerald
Overweight
Mar 3, 25 HC Wainwright & Co.
Buy
Jan 27, 25 HC Wainwright & Co.
Buy
Jan 10, 25 Cantor Fitzgerald
Overweight
Dec 2, 24 Citigroup
Buy

Institutional Ownership

Similar stocks

HITI logo
High Tide (HITI)
TuHURA Biosciences (HURA)
DRTS logo
Alpha Tau Medical (DRTS)
ELDN logo
Eledon Pharmaceuticals (ELDN)
UTMD logo
Utah Medical Products (UTMD)
TriSalus Life Sciences (TLSI)
Aardvark Therapeutics (AARD)
INMB logo
INmune Bio (INMB)
INBX logo
Inhibrx Biosciences (INBX)
  • What is the ticker symbol for Voyager Therapeutics?
  • Does Voyager Therapeutics pay dividends?
  • What sector is Voyager Therapeutics in?
  • What industry is Voyager Therapeutics in?
  • What country is Voyager Therapeutics based in?
  • When did Voyager Therapeutics go public?
  • Is Voyager Therapeutics in the S&P 500?
  • Is Voyager Therapeutics in the NASDAQ 100?
  • Is Voyager Therapeutics in the Dow Jones?
  • When was Voyager Therapeutics's last earnings report?
  • When does Voyager Therapeutics report earnings?
  • Should I buy Voyager Therapeutics stock now?

What is the ticker symbol for Voyager Therapeutics?

The ticker symbol for Voyager Therapeutics is NASDAQ:VYGR

Does Voyager Therapeutics pay dividends?

No, Voyager Therapeutics does not pay dividends

What sector is Voyager Therapeutics in?

Voyager Therapeutics is in the Healthcare sector

What industry is Voyager Therapeutics in?

Voyager Therapeutics is in the Biotechnology industry

What country is Voyager Therapeutics based in?

Voyager Therapeutics is headquartered in United States

When did Voyager Therapeutics go public?

Voyager Therapeutics's initial public offering (IPO) was on November 11, 2015

Is Voyager Therapeutics in the S&P 500?

No, Voyager Therapeutics is not included in the S&P 500 index

Is Voyager Therapeutics in the NASDAQ 100?

No, Voyager Therapeutics is not included in the NASDAQ 100 index

Is Voyager Therapeutics in the Dow Jones?

No, Voyager Therapeutics is not included in the Dow Jones index

When was Voyager Therapeutics's last earnings report?

Voyager Therapeutics's most recent earnings report was on Mar 11, 2025

When does Voyager Therapeutics report earnings?

The next expected earnings date for Voyager Therapeutics is May 13, 2025

Should I buy Voyager Therapeutics stock now?

As of today, analysts generally recommend a 'Strong buy' rating. However, it's important to do your own research and consider your financial situation before making any investment decisions
On this page